Skip to main content
. 2015 Mar 24;6(2):101–111. doi: 10.1007/s13300-015-0106-2

Table 2.

Receptor binding and metabolic and mitogenic properties of insulin aspart and insulin degludec

Human insulin Insulin degludec Insulin aspart
Insulin receptor affinity 100% 13–15% 92%
IGF receptor affinity 100% 2% 81%
Metabolic potency 100% 8–20% 101%
Mitogenic potency 100% 4–14% 58%
Mitogenic/metabolic potency ratio 1 <1 <1